Effects of EGCG on intestinal microflora and metabolomics in healthy mice

  • YUE Chenbo ,
  • LI Minyu ,
  • YU Leilei ,
  • TIAN Fengwei ,
  • WANG Jialin ,
  • ZHAI Qixiao
Expand
  • 1(School of Food Science and Technology, Jiangnan University, Wuxi 214000, China)
    2(The First Affiliated Hospital of Naval Medical University, Shanghai 200433, China)

Received date: 2021-12-29

  Revised date: 2022-02-21

  Online published: 2022-11-01

Abstract

The health benefits of green tea are largely attributed to the main ingredient catechin, of which epigallocatechin gallate (EGCG) accounts for 50%-70%. EGCG is a flavone-3-ol polyphenol compound with phenolic antioxidant properties. The six o-phenolic hydroxyl groups in the structure make it superior to other catechins in many properties. EGCG has a low bioavailability, digestion and absorption mainly occur in the small intestine, so EGCG can interact with intestinal microbes to affect the composition of bacteria and metabolites. The interactions between intestinal microbes and the host are one of the important ways for substances to exert physiological functions. At present, there are few relevant studies, which only focus on animal disease models such as obesity and colitis. In this study, SPF C57BL/6J healthy mice were selected for a 4-week EGCG supplement experiment. 16S rRNA sequencing, short-chain fatty acid determination, untargeted metabolite analysis, plasma biochemical analysis, and other analytical methods were chosen to explore the changes of intestinal flora and fecal metabolites in healthy mice after EGCG intake and filled the relevant research gaps. Fecal flora 16S rRNA sequencing results showed that EGCG could significantly change the structure and composition of intestinal flora in healthy mice, and increase the abundance of beneficial bacteria such as Akkermansia and Bifidobacterium. Meanwhile, EGCG could inhibit the colonization of harmful bacteria such as Muribaculaceae and promote the health of intestinal flora. Akkermansia was the most obvious changing genus after EGCG intake among those beneficial bacteria. It is worth noting that previous studies have proved that EGCG can promote the increase of Akkermansia abundance in mice with obesity and colitis disease. This study demonstrated that EGCG also could promote the abundance of Akkermansia in healthy mice and combined with a recent in vitro experiment and provided evidence for targeted promotion of Akkermansia abundance. Targeted metabolite analysis, named short-chain fatty acid content determination, showed that EGCG intake increased the contents of acetic acid, propionic acid, and butyric acid significantly, which was associated with the increased abundance of short-chain fatty acid producing bacteria. The results of untargeted metabolite analysis showed that thymidine, 2′-deoxyguanosine, guanine, 2′-deoxyadenosine, and other metabolites related to antiviral and anticancer drugs were increased compared with the control group. Based on the Spearman correlation analysis between differential bacteria and differential metabolites, we speculated that EGCG might promote the increase of 2′-deoxyguanosine, guanine, 2′-deoxyadenosine, and other substances by increasing the proliferation of Romboutsia, Faecalibacterium, and Anaerostipes. These contribute to play EGCG antiviral and anti-cancer physiological functions. Finally, we demonstrated that the physiological functions based on differential bacteria and metabolites, and also proved EGCG could improve the glucose metabolism level of mice significantly. This study provides a scientific basis for the mechanism of EGCG for health benefits and the development of dietary supplement products.

Cite this article

YUE Chenbo , LI Minyu , YU Leilei , TIAN Fengwei , WANG Jialin , ZHAI Qixiao . Effects of EGCG on intestinal microflora and metabolomics in healthy mice[J]. Food and Fermentation Industries, 2022 , 48(19) : 70 -78 . DOI: 10.13995/j.cnki.11-1802/ts.030631

References

[1] KHAN N, MUKHTAR H.Tea polyphenols in promotion of human health[J].Nutrients, 2018, 11(1):39.
[2] GAN R Y, LI H B, SUI Z Q, et al.Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG):An updated review[J].Critical Reviews in Food Science and Nutrition, 2018, 58(6):924-941.
[3] 韩晓阳, 陈悦, 杨洋, 等.表没食子儿茶素没食子酸酯的抗感染作用研究进展[J].中国现代应用药学, 2021, 38(20):2 616-2 620.
HAN X Y, CHEN Y, YANG Y, et al.Advances in the anti-infective effects of epigallocatechin gallate[J].Chinese Journal of Modern Applied Pharmacy, 2021, 38(20):2 616-2 620.
[4] XI Y, XU P F.Diabetes and gut microbiota[J].World Journal of Diabetes, 2021, 12(10):1 693-1 703.
[5] LEEMING E R, JOHNSON A J, SPECTOR T D, et al.Effect of diet on the gut microbiota:Rethinking intervention duration[J].Nutrients, 2019, 11(12):2862.
[6] WANG S Z, LI Z L, MA Y T, et al.Immunomodulatory effects of green tea polyphenols[J].Molecules (Basel, Switzerland), 2021, 26(12):3755.
[7] EVERARD A, BELZER C, GEURTS L, et al.Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity[J].Proceedings of the National Academy of Sciences of the United States of America, 2013, 110(22):9 066-9 071.
[8] WU Z H, HUANG S M, LI T T, et al.Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis[J].Microbiome, 2021, 9(1):184.
[9] SHENG L L, JENA P K, LIU H X, et al.Obesity treatment by epigallocatechin-3-gallate-regulated bile acid signaling and its enriched Akkermansia muciniphila[J].FASEB Journal:Official Publication of the Federation of American Societies for Experimental Biology, 2018, 32(12):fj201800370R.
[10] WANG L L, HU L J, XU Q, et al.Bifidobacteria exert species-specific effects on constipation in BALB/c mice[J].Food & Function, 2017, 8(10):3 587-3 600.
[11] FAN Z X, ROSS R P, STANTON C, et al.Lactobacillus casei CCFM1074 alleviates collagen-induced arthritis in rats via balancing treg/Th17 and modulating the metabolites and gut microbiota[J].Frontiers in Immunology, 2021, 12:680073.
[12] DERRIEN M, VAUGHAN E E, PLUGGE C M, et al. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium[J]. International Journal of Systematic and Evolutionary Microbiology, 2004, 54, 1 469-1 476.
[13] DEPOMMIER C, EVERARD A, DRUART C, et al.Supplementation with Akkermansia muciniphila in overweight and obese human volunteers:A proof-of-concept exploratory study[J].Nature Medicine, 2019, 25(7):1 096-1 103.
[14] ROUTY B, LE CHATELIER E, DEROSA L, et al.Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors[J].Science, 2018, 359(6 371):91-97.
[15] REUNANEN J, KAINULAINEN V, HUUSKONEN L, et al.Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of the epithelial cell layer[J].Applied and Environmental Microbiology, 2015, 81(11):3 655-3 662.
[16] XIA Y, ZHANG X X, JIANG M X, et al.In vitro co-metabolism of epigallocatechin-3-gallate (EGCG) by the mucin-degrading bacterium Akkermansia muciniphila[J].PLoS One, 2021, 16(12):e0260757.
[17] PEREIRA F C, WASMUND K, COBANKOVIC I, et al.Rational design of a microbial consortium of mucosal sugar utilizers reduces Clostridiodes difficile colonization[J].Nature Communications, 2020, 11(1):5 104.
[18] HERP S, DURAI RAJ A C, SALVADO SILVA M, et al.The human symbiont Mucispirillum schaedleri:Causality in health and disease[J].Medical Microbiology and Immunology, 2021, 210(4):173-179.
[19] ANONYE B O.Commentary:Dietary polyphenols promote growth of the gut bacterium Akkermansia muciniphila and attenuate high-fat diet-induced metabolic syndrome[J].Frontiers in Immunology, 2017, 8:850.
[20] 钟方为, 李庚喜, 曾立.基于肠道菌群和短链脂肪酸代谢探讨绞股蓝总皂苷改善大鼠非酒精性脂肪肝病的实验研究[J].中国中药杂志, 2022, 47(9):2 500-2 508.
ZHONG F W, LI G X, ZENG L.Gynostemma pentaphyllum saponins alleviate non-alcoholic fatty liver disease in rats by regulating intestinal flora and short-chain fatty acid metabolism[J].China Journal of Chinese Materia Medica, 2022, 47(9):2 500-2 508.
[21] COLLINS Q F, LIU H Y, PI J B, et al.Epigallocatechin-3-gallate (EGCG), A green tea polyphenol, suppresses hepatic gluconeogenesis through 5′-AMP-activated protein kinase[J].Journal of Biological Chemistry, 2007, 282(41):30 143-30 149.
[22] 刘振云, 左高隆, 林勇.茶叶中EGCG改善肥胖大鼠肠黏膜屏障损伤的作用研究[J].茶叶通讯, 2021, 48(3):529-535.
LIU Z Y, ZUO G L, LIN Y.Effects of EGCG in tea on improving intestinal mucosal barrier injury in obese rats[J].Journal of Tea Communication, 2021, 48(3):529-535.
Outlines

/